» Articles » PMID: 16407512

Treatment of Acute Lymphoblastic Leukemia

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2006 Jan 13
PMID 16407512
Citations 700
Authors
Affiliations
Soon will be listed here.
Citing Articles

Asciminib resistance of a new BCR::ABL1 p.I293_K294insSSLRD mutant detected in a Ph + ALL patient.

Cullot G, Lagarde V, Cayuela J, Prouzet-Mauleon V, Turcq B, Hicheri Y Ann Hematol. 2025; .

PMID: 39774950 DOI: 10.1007/s00277-024-06142-8.


Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic Leukemia.

Navas-Acosta J, Hernandez-Sanchez A, Gonzalez T, Villaverde Ramiro A, Santos S, Miguel C Cancers (Basel). 2025; 16(24.

PMID: 39766099 PMC: 11674736. DOI: 10.3390/cancers16244200.


[Clinical characteristics and treatment efficacy of newly diagnosed acute leukemia in the plateau].

He Q, Lai A, Zhang A, Wang L, Chen X, Qiu S Zhonghua Xue Ye Xue Za Zhi. 2025; 45(12):1106-1112.

PMID: 39765351 PMC: 11886690. DOI: 10.3760/cma.j.cn121090-20240514-00182.


Pharmacological inhibition of the MAP2K7 kinase in human disease.

Lacorazza H Front Oncol. 2024; 14:1486756.

PMID: 39717752 PMC: 11663940. DOI: 10.3389/fonc.2024.1486756.


Genomic variations associated with risk and protection against vincristine-induced peripheral neuropathy in pediatric cancer patients.

Mufti K, Cordova M, Scott E, Trueman J, Lovnicki J, Loucks C NPJ Genom Med. 2024; 9(1):56.

PMID: 39500896 PMC: 11538333. DOI: 10.1038/s41525-024-00443-7.